| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.65B | +12.8% |
| Cost of Revenue | $2.78B | +11.2% |
| Gross Profit | $869.0M | +18.1% |
| R&D Expense | $129.0M | +40.2% |
| SG&A Expense | $497.0M | +20.0% |
| Operating Income | $348.0M | +18.8% |
| Pre-tax Income | $336.0M | +27.3% |
| Income Tax | $58.0M | +13.7% |
| Net Income | $278.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $647.0M | +8.2% |
| Accounts Receivable | $334.0M | +32.0% |
| Inventory | $352.0M | -1.7% |
| Current Assets | $2.33B | +7.5% |
| Total Assets | $4.49B | +7.2% |
| Current Liabilities | $1.23B | +10.3% |
| Long-term Debt | $348.0M | -4.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $366.0M | +35.1% |
| Capital Expenditures | $139.0M | +63.5% |
| Investing Cash Flow | -$154.0M | -83.3% |
| Financing Cash Flow | -$163.0M | -191.1% |
| Free Cash Flow | $227.0M | +22.0% |
| +30.5% |
| EPS (Basic) | $1.05 | +29.6% |
| EPS (Diluted) | $1.03 | +28.7% |
| Stockholders' Equity |
| $2.73B |
| +6.8% |